Provided by Tiger Trade Technology Pte. Ltd.

OCUMENSION-B

5.285
-0.030-0.56%
Volume:64.00K
Turnover:338.62K
Market Cap:4.31B
PE:-22.65
High:5.340
Open:5.320
Low:5.270
Close:5.315
52wk High:12.070
52wk Low:4.040
Shares:815.00M
HK Float Shares:815.00M
Volume Ratio:0.18
T/O Rate:0.01%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.233
ROE:-4.26%
ROA:-2.48%
PB:1.00
PE(LYR):-22.65
PS:4.59

Loading ...

Ocumension Therapeutics Says Tim Ruan Resigns as CFO

Reuters
·
Jul 06

Frequent Price Fluctuations and Policy Tailwinds: Is a Pharmaceutical Rally Brewing?

Deep News
·
Jul 06

ASCLETIS-B Submits Two IND Applications to US FDA for Obesity Treatments: Monthly Peptide Amylin Receptor Agonist ASC36 and ASC36_35 Combination Monthly Injection

Stock News
·
Jul 06

Pharmaceutical Giant Appoints AI Executive to Lead Digital Innovation

Deep News
·
Jul 04

Ocumension Jumps Most in Three Months on China Nod for New Drug Application

Reuters
·
Jul 03

Ocumension Says China NMPA Approves Ot-502 New Drug Application for Postoperative Ocular Inflammation

Reuters
·
Jul 02

Ocumension Therapeutics - Nmpa Approves Ot-502 (dexycu) New Drug Application in China

THOMSON REUTERS
·
Jul 02

Investor Compensation Cases for Changyao Holdings and Poly Pharmaceutical Set for Court Proceedings

Deep News
·
Jul 02

Huiyu Pharmaceutical Inks Strategic Partnership Deal with Avenacy

Stock News
·
Jul 02

Anthropic Launches Internal Drug Discovery Initiative and AI Research Platform, Focusing on Neglected Diseases

Deep News
·
Jul 01

Anthropic Launches Claude Science to Revolutionize Research and Drug Discovery

Stock News
·
Jul 01

Ocumension Therapeutics Says Tim Ruan Resigns as CFO

Reuters
·
Jun 30

Ocumension Therapeutics Announces CFO Departure and Corporate Secretary Restructure

Bulletin Express
·
Jun 30

Ocumension Therapeutics - Tim Ruan Resigns as CFO, Joint Company Secretary, and Authorized Representative Effective June 30, 2026

THOMSON REUTERS
·
Jun 30

Ocumension details updated board composition and committee assignments

Bulletin Express
·
Jun 30

Ocumension Therapeutics: AGM Approves All Motions; Beibei Zhuang Appointed Independent Director and Audit Chair

Bulletin Express
·
Jun 30

Ocumension Therapeutics Files List of Board, Board Committee Members with Disclosure Responsibilities

Reuters
·
Jun 30

Ocumension Therapeutics Appoints Beibei Zhuang as Independent Director, Audit Committee Chair

Reuters
·
Jun 30

Huiyu Pharmaceutical Subsidiary Receives Clinical Trial Approval for HY-1016 Sustained-Release Injection

Stock News
·
Jun 30

ASCLETIS-B Shares Surge Over 7% on FDA IND Approval for ASC35 Phase I Study and GIC's Consistent Share Purchases

Stock News
·
Jun 29